Sign In
Buy HURN
Huron Consulting Group Earnings Calls
| Release date | Jul 30, 2026 |
| EPS estimate | $2.13 |
| EPS actual | - |
| Revenue estimate | 448.975M |
| Revenue actual | - |
| Expected change | +/- 3.18% |
| Release date | May 05, 2026 |
| EPS estimate | $1.58 |
| EPS actual | $1.73 |
| EPS Surprise | 9.49% |
| Revenue estimate | 437.123M |
| Revenue actual | 443.712M |
| Revenue Surprise | 1.51% |
| Release date | Feb 24, 2026 |
| EPS estimate | $1.94 |
| EPS actual | $2.17 |
| EPS Surprise | 11.86% |
| Revenue estimate | 433.621M |
| Revenue actual | 432.28M |
| Revenue Surprise | -0.309% |
| Release date | Oct 28, 2025 |
| EPS estimate | $1.88 |
| EPS actual | $2.10 |
| EPS Surprise | 11.70% |
| Revenue estimate | 418.127M |
| Revenue actual | 441.284M |
| Revenue Surprise | 5.54% |
Last 4 Quarters for Huron Consulting Group
Below you can see how HURN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 28, 2025 |
| Price on release | $152.48 |
| EPS estimate | $1.88 |
| EPS actual | $2.10 |
| EPS surprise | 11.70% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $152.45 |
| Oct 23, 2025 | $153.14 |
| Oct 24, 2025 | $153.07 |
| Oct 27, 2025 | $153.64 |
| Oct 28, 2025 | $152.48 |
| Oct 29, 2025 | $169.61 |
| Oct 30, 2025 | $165.40 |
| Oct 31, 2025 | $164.44 |
| Nov 03, 2025 | $165.70 |
| 4 days before | 0.0197% |
| 4 days after | 8.67% |
| On release day | 11.23% |
| Change in period | 8.69% |
| Release date | Feb 24, 2026 |
| Price on release | $126.36 |
| EPS estimate | $1.94 |
| EPS actual | $2.17 |
| EPS surprise | 11.86% |
| Date | Price |
|---|---|
| Feb 18, 2026 | $133.62 |
| Feb 19, 2026 | $130.94 |
| Feb 20, 2026 | $131.53 |
| Feb 23, 2026 | $127.16 |
| Feb 24, 2026 | $126.36 |
| Feb 25, 2026 | $133.31 |
| Feb 26, 2026 | $143.29 |
| Feb 27, 2026 | $141.40 |
| Mar 02, 2026 | $144.45 |
| 4 days before | -5.43% |
| 4 days after | 14.32% |
| On release day | 5.50% |
| Change in period | 8.11% |
| Release date | May 05, 2026 |
| Price on release | $132.22 |
| EPS estimate | $1.58 |
| EPS actual | $1.73 |
| EPS surprise | 9.49% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $128.48 |
| Apr 30, 2026 | $130.67 |
| May 01, 2026 | $131.29 |
| May 04, 2026 | $132.10 |
| May 05, 2026 | $132.22 |
| May 06, 2026 | $120.11 |
| May 07, 2026 | $124.78 |
| May 08, 2026 | $119.97 |
| May 11, 2026 | $115.94 |
| 4 days before | 2.91% |
| 4 days after | -12.31% |
| On release day | -9.16% |
| Change in period | -9.76% |
| Release date | Jul 30, 2026 |
| Price on release | - |
| EPS estimate | $2.13 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 06, 2026 | $100.01 |
| Jul 07, 2026 | $105.93 |
| Jul 08, 2026 | $103.01 |
| Jul 09, 2026 | $102.51 |
| Jul 10, 2026 | $105.85 |
Huron Consulting Group Earnings Call Transcript Summary of Q1 2026
Huron reported a strong start to 2026 with first-quarter revenues before reimbursable expenses (RBR) up 12% YoY to $443.7M driven by growth across Healthcare (record RBR), Education and Commercial. Adjusted EBITDA margin expanded to 11.4% of RBR and management affirmed full-year 2026 guidance (RBR $1.78B–$1.86B; adjusted EBITDA 14.5%–15% of RBR; adjusted EPS $8.35–$9.15). Healthcare performance improvement and managed services were primary drivers; Commercial grew substantially (including tuck‑ins) and Education showed steady, digital-led demand. Bookings and backlog remained strong (bookings up >20% across all segments over the trailing six months; pipeline near record levels). First‑quarter cash flow was negative due to annual bonus payments and accelerated share repurchases (1.1M shares, $155.5M), increasing net debt to $829.5M and leverage to 3.1x (seasonal high); management targets leverage of 2.0x–2.5x by year‑end. Management is bullish on AI as a durable growth and margin opportunity, has increased AI investments and expects AI to be integrated across industry offerings. Capital deployment priorities remain: disciplined tuck‑in M&A, continued share buybacks (paced to manage leverage), and generating strong free cash flow over the year.
